Mao Inhibitors + Lacosamide Oral Solution Interaction
Moderateinteraction on record
Description
Patients with renal or hepatic impairment taking strong CYP3A4 inhibitors may have significant increase in lacosamide exposure. Dose reduction may be necessary.
Mechanism
CYP3A4 inhibition
Source: NLP:lacosamide oral solution